Abbott agrees to pay $670 million to settle some lawsuits involving its infant formula products for preterm babies, according to reports from multiple outlets. The settlement amount is reported as US$670 million (about $670 million).
The cases concern claims that Abbott’s cow’s milk-based formulas used for preterm infants can contribute to necrotizing enterocolitis (a serious bowel disease). The reports say hundreds of lawsuits have been filed and that the allegations relate specifically to preterm infant formula, though details about which claims are included in the settlement may vary by case and jurisdiction.
While the outlets largely focus on the size of the settlement and the underlying medical allegation, they do not provide the same level of detail on the number of cases covered, the specific product lines involved, or how courts or parties characterize the settlement terms. The agreement is presented as a resolution of at least a portion of the pending litigation.
